The active substance Cabergoline is aimed at reducing the secretion of the hormone Prolactin, increasing libido and the speed of recovery after intercourse, as well as lowering blood pressure. This substance belongs to the alcoid derivatives of ergot, demonstrates the inhibitory function of dopamine D2 receptors. Cabergoline acts as a modern substitute for bromocriptine, while it differs from it in harmlessness and greater efficiency.
Packaging video review Cabaser Original 1 mg Pfizer Labs
removal of accumulated fluid from the body;
significant increase in appetite;
effective burning of fatty deposits;
minimal fluctuations in body weight;
increased venous tracing.
The initial dosage of the drug is 0.25 mg orally 2 times a week. If indicated, the dosage can be increased to a maximum level of 1 mg 2 times a week. However, it is forbidden to change the dose of admission more often than once every 4 weeks.
Regular monitoring of the level of prolactin in plasma allows you to make a decision on the need for further administration of the drug. If a stable maintenance of normal plasma prolactin levels is observed within 6 months, therapy can be discontinued. However, the continuation of the control of the prolactin content is imperative so that, if necessary, treatment is promptly resumed.
Cabergoline, subject to the recommended intake and dosage regimen, rarely has side effects, in most cases it does not have them at all. Reviews of Cabergoline, as a drug that causes weakness and reduces immunity, were written by people who exceed the recommended dose.